Menu
No results found.
Weekly Share Price & Valuation Overview
Optomed Oyj
Optomed Oyj, together with its subsidiaries, manufactures and sells handheld fundus cameras in Finland, rest of Europe, and internationally. The company operates in two segments, Devices and Software. It develops, manufactures, and sells fundus cameras for ophthalmologists, pediatricians, endocrinologists, neurologists, and primary health care professionals; and provides professional IT consulting services for government institutions. The company also provides camera products under the Optomed Smartscope Pro, Optomed Aurora, Optomed Aurora AEYE, and Optomed Polaris brand names, as well as OEM cameras under the Volk Optical, Carl Zeiss Meditec, and Topcon brands. The company provides Avenue AI, an AI streamlines eye specialists' work and minimises screening costs; Avenue Eye Screen, a workflow management software for screening and monitoring of eye diseases; Avenue Flow, an eyecare management software; and Avenue Telemedicine, a remote analysis solution. In addition, it offers Cancer Screen, a screening process management software; Optomed RIS, a software solution for healthcare imaging units; Sectra PACS, a modular system for healthcare providers; Optomed Service Portal, a support function for healthcare units; Cephalometry, a powerful, flexible, and easy-to-use Windows software for orthodontics, oral and maxillofacial surgery; and Pathology PACS, which allows digital pathology images to be reviewed and shared. The company sells its products through OEMs, distributors, and direct sales to hospitals, eye clinics, and optician chains and stores. Optomed Oyj was incorporated in 2004 and is headquartered in Oulu, Finland.
- High gross margin (≥35%) suggests strong pricing power or cost control.
- Quick ratio ≥1.0 indicates obligations can be met without inventory.
- Net cash balance sheet provides flexibility for downturns and investment.
- Negative free cash flow — operations may rely on external financing.
- Market Cap Total equity value of the company (share price × shares outstanding).
- EUR 75.24M
- Enterprise Value Operating value: market cap + total debt − cash.
- EUR 72.03M
- Total Revenue (TTM) Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
- EUR 16.07M
- Gross Profit (TTM) Revenue minus cost of goods sold over the last twelve months. Hidden for financial institutions or if redundant.
- EUR 10.20M
- EBITDA (TTM) Earnings before interest, taxes, depreciation and amortization (TTM). Hidden for financials or if implausible.
- EUR -4.91M
- Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
- EUR 0.81
- EPS (TTM) Earnings per share over the last twelve months (may be estimated from net income ÷ shares).
- -0.29
- Shares Outstanding
- 19.67M
- Float Shares
- 14.53M
- Implied Shares Outstanding
- 19.67M
- Operating Margin (TTM) Operating income ÷ revenue over the last twelve months (reconciled when possible).
-
-40.18%
- EBITDA Margin (TTM) Reconciled EBITDA ÷ revenue over the last twelve months (suppressed if EBITDA implausible/financials).
-
-30.52%
- Gross Margin (TTM) Reconciled Strong Gross profit ÷ revenue over the last twelve months (reconciled when possible).
-
63.46%
- Profit Margin (TTM) Net income ÷ revenue over the last twelve months (reconciled when possible).
-
-36.03%
- ROA Return on assets: net income ÷ total assets.
-
-11.37%
- ROE Return on equity: net income ÷ shareholder equity.
-
-25.19%
- Revenue Growth Year-over-year revenue growth.
-
9.70%
- Quick Ratio Adequate Liquid current assets ÷ current liabilities (ex-inventory).
- 1.84
- Debt to Equity Total debt ÷ shareholder equity; leverage.
- 0.15
- Total Cash Cash and equivalents.
- EUR 7.09M
- Total Debt Short + long-term interest-bearing debt.
- EUR 3.14M
- Net Debt Net Cash Total debt − cash (negative = net cash).
- EUR -3.95M
- Debt / EBITDA Leverage relative to operating earnings; lower is safer.
- -0.64
- Operating Cash Flow (TTM) Cash generated by core operations (pre-capex).
- EUR -1.83M
- Free Cash Flow (TTM) Cash after capex; funds buybacks, dividends, and debt paydown.
- EUR -3.16M
- OCF Margin (TTM) Operating cash flow ÷ revenue (TTM).
-
-11.40%
- FCF Margin (TTM) Free cash flow ÷ revenue (TTM).
-
-19.64%
- Cash Conversion (OpCF/EBITDA)
- 0.37
- Margins shown on a TTM basis. “Reconciled” = numerator ÷ TTM revenue for internal consistency.
- Cash Flow section is displayed only when figures are self-consistent (and hidden for financials).
Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.